AH Capital Management »

Galecto shares owned by AH Capital Management

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by AH Capital Management from 13F filings

Historical chart of AH Capital Management investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by AH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by AH Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $32M 1.2M 25.90

More positions owned by AH Capital Management

Navan Cl A (NAVN)
Figma Class A Com Stk (FIG)
Meta Platforms Cl A (META)
Revolution Medicines (RVMD)
Nautilus Biotechnology (NAUT)
Block Cl A (XYZ)
Bioage Labs (BIOA)
Maze Therapeatics (MAZE)
Erasca (ERAS)
Damora Therapeutics Com New (DMRA)
Omada Health (OMDA)
Camp4 Therapeutics Corp (CAMP)
Aktis Oncology
Bitgo Holdings Com Shs Cl A
Ginkgo Bioworks Holdings Cl A New (DNA)

View all positions for AH Capital Management

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto